Ora Oxford University Research
metadata only
Studies on: roles and therapeutic potential of isocitrate dehydrogenase mutations in cancer and inhibition of the SARS-CoV-2 main protease
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Altered sphingolipid metabolism is associated with osimertinib resistance in non-small cell lung cancer#201215
- CIrCuLAting Dna ESr1 Gene Mutations Analysis#980316
- Molecular architecture of the human citrate synthase–malate dehydrogenase 2 metabolon#485162
- New Insights into the Interaction of Class II Dihydroorotate Dehydrogenases with Ubiquinone in Lipid Bilayers as a Function of Lipid Composition#176792
- Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer#805698
Record · ID 228150
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive